These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31670581)

  • 21. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adaptive Radiotherapy for Head and Neck Cancer.
    Surucu M; Shah KK; Roeske JC; Choi M; Small W; Emami B
    Technol Cancer Res Treat; 2017 Apr; 16(2):218-223. PubMed ID: 27502958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Application of a Hybrid RapidArc Radiotherapy Technique for Locally Advanced Lung Cancer.
    Silva SR; Surucu M; Steber J; Harkenrider MM; Choi M
    Technol Cancer Res Treat; 2017 Apr; 16(2):224-230. PubMed ID: 27680023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC.
    Ramella S; Fiore M; Silipigni S; Zappa MC; Jaus M; Alberti AM; Matteucci P; Molfese E; Cornacchione P; Greco C; Trodella L; Ippolito E; D'Angelillo RM
    J Thorac Oncol; 2017 Jul; 12(7):1122-1130. PubMed ID: 28428149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adaptive intensity-modulated radiotherapy in head-and-neck cancer: A volumetric and dosimetric study.
    Burela N; Soni TP; Patni N; Natarajan T
    J Cancer Res Ther; 2019; 15(3):533-538. PubMed ID: 31169216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
    Zhong H; Siddiqui SM; Movsas B; Chetty IJ
    Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting.
    Agrawal S; Kumar S; Maurya AK
    Br J Radiol; 2017 Feb; 90(1070):20140234. PubMed ID: 27897060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of induction chemotherapy on the dosimetric parameters of subsequent radiotherapy: an investigation of 30 consecutive patients with locally-advanced non-small cell lung cancer and modern radiation planning techniques.
    Grant JD; Sobremonte A; Hillebrandt E; Allen PK; Gomez DR
    Radiat Oncol; 2015 Jan; 10():32. PubMed ID: 25636372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
    Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
    Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Finazzi T; Palacios MA; Spoelstra FOB; Haasbeek CJA; Bruynzeel AME; Slotman BJ; Lagerwaard FJ; Senan S
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(4):933-941. PubMed ID: 30928360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head and Neck Margin Reduction With Adaptive Radiation Therapy: Robustness of Treatment Plans Against Anatomy Changes.
    van Kranen S; Hamming-Vrieze O; Wolf A; Damen E; van Herk M; Sonke JJ
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):653-60. PubMed ID: 27681762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    Xiao L; Liu N; Zhang G; Zhang H; Gao S; Fu Z; Wang S; Yu Q; Yu J; Yuan S
    PLoS One; 2017; 12(1):e0170901. PubMed ID: 28125698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515.
    Bradley J; Bae K; Choi N; Forster K; Siegel BA; Brunetti J; Purdy J; Faria S; Vu T; Thorstad W; Choy H
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):435-41.e1. PubMed ID: 21075551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prediction model for dosimetric-based lung adaptive radiotherapy.
    Ma C; Tian Z; Wang R; Feng Z; Jiang F; Hu Q; Yang F; Shi A; Wu H
    Med Phys; 2022 Oct; 49(10):6319-6333. PubMed ID: 35649103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dosimetric Comparison of Real-Time MRI-Guided Tri-Cobalt-60 Versus Linear Accelerator-Based Stereotactic Body Radiation Therapy Lung Cancer Plans.
    Wojcieszynski AP; Hill PM; Rosenberg SA; Hullett CR; Labby ZE; Paliwal B; Geurts MW; Bayliss RA; Bayouth JE; Harari PM; Bassetti MF; Baschnagel AM
    Technol Cancer Res Treat; 2017 Jun; 16(3):366-372. PubMed ID: 28168936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A feasibility study of dynamic adaptive radiotherapy for nonsmall cell lung cancer.
    Kim M; Phillips MH
    Med Phys; 2016 May; 43(5):2153. PubMed ID: 27147327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits of adaptive radiation therapy in lung cancer as a function of replanning frequency.
    Dial C; Weiss E; Siebers JV; Hugo GD
    Med Phys; 2016 Apr; 43(4):1787. PubMed ID: 27036576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Online dosimetric evaluation of larynx SBRT: A pilot study to assess the necessity of adaptive replanning.
    Mao W; Rozario T; Lu W; Gu X; Yan Y; Jia X; Sumer B; Schwartz DL
    J Appl Clin Med Phys; 2017 Jan; 18(1):157-163. PubMed ID: 28291932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.